Anna Diana

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data

Margherita Rimini, Lorenzo Fornaro, Sara Lonardi et al. · Liver International · 2023 · 117 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Sabino De Placido, Ciro Gallo, Michelino De Laurentiis et al. · The Lancet Oncology · 2018 · 88 citations · Full text

Medicine, Endocrinology, Oncology +11

Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: a propensity score-matched analysis

Michele Orditura, Gennaro Galizia, Anna Diana et al. · ESMO Open · 2016 · 81 citations · Full text

Medicine, Biostatistics, Oncology +13

G-CSF and GM-CSF Modify Neutrophil Functions at Concentrations found in Cystic Fibrosis

Stefano Castellani, Susanna D’Oria, Anna Diana et al. · Scientific Reports · 2019 · 68 citations · Full text

Life Sciences, Clinical Sciences, Immunology +16

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice

Ferdinando De Vita, Jole Ventriglia, Antonio Febbraro et al. · BMC Cancer · 2016 · 58 citations · Full text

Medicine, Oncology, Pharmacology +13